# Melatonin Agonist for Shift-time Workers.

> **NCT07382843** · PHASE4 · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 61 (actual)

## Conditions studied

- Circadian Rhythm Disorders

## Interventions

- **DRUG:** Ramelteon

## Key facts

- **NCT ID:** NCT07382843
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-04
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382843, "Melatonin Agonist for Shift-time Workers.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07382843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*